LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

Atossa Genetics Inc

Closed

0.76 1.33

Overview

Share price change

24h

Current

Min

0.75

Max

0.76

Key metrics

By Trading Economics

Income

-1.7M

-8.4M

Employees

15

EBITDA

-1.3M

-8.4M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+640.79% upside

Dividends

By Dow Jones

Next Earnings

11 Nov 2025

Market Stats

By TradingEconomics

Market Cap

-451K

98M

Previous open

-0.57

Previous close

0.76

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Genetics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

29 Aug 2025, 18:43 UTC

Major Market Movers

Privia Health Shares Advance on Outlook Bump From Medicare Savings

29 Aug 2025, 15:07 UTC

Acquisitions, Mergers, Takeovers

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

30 Aug 2025, 08:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Auto & Transport Roundup: Market Talk

29 Aug 2025, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Auto & Transport Roundup: Market Talk

29 Aug 2025, 20:24 UTC

Earnings

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

29 Aug 2025, 20:17 UTC

Earnings

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 Aug 2025, 19:18 UTC

Market Talk

Oil Futures End Week With Modest Gains -- Market Talk

29 Aug 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

29 Aug 2025, 18:36 UTC

Earnings

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

29 Aug 2025, 18:26 UTC

Earnings

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

29 Aug 2025, 17:48 UTC

Market Talk

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

29 Aug 2025, 17:10 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

29 Aug 2025, 16:57 UTC

Earnings

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 Aug 2025, 16:30 UTC

Acquisitions, Mergers, Takeovers

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

29 Aug 2025, 16:28 UTC

Acquisitions, Mergers, Takeovers

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

29 Aug 2025, 16:27 UTC

Acquisitions, Mergers, Takeovers

BBVA: Adjustment Outlined in Announcement on May 9, 2024

29 Aug 2025, 16:26 UTC

Acquisitions, Mergers, Takeovers

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

29 Aug 2025, 16:25 UTC

Acquisitions, Mergers, Takeovers

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

29 Aug 2025, 16:24 UTC

Acquisitions, Mergers, Takeovers

BBVA Adjusts Offer for Banco de Sabadell

29 Aug 2025, 16:23 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

29 Aug 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29 Aug 2025, 16:06 UTC

Market Talk

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

29 Aug 2025, 15:12 UTC

Market Talk
Earnings

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

29 Aug 2025, 15:09 UTC

Earnings

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

29 Aug 2025, 15:01 UTC

Market Talk

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

29 Aug 2025, 14:49 UTC

Earnings

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 Aug 2025, 14:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29 Aug 2025, 14:49 UTC

Market Talk

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

29 Aug 2025, 14:48 UTC

Earnings

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

29 Aug 2025, 14:43 UTC

Market Talk

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

Peer Comparison

Price change

Atossa Genetics Inc Forecast

Price Target

By TipRanks

640.79% upside

12 Months Forecast

Average 5.63 USD  640.79%

High 7.5 USD

Low 4 USD

Based on 4 Wall Street analysts offering 12 month price targets forAtossa Genetics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.